dactylariol has been researched along with 1,10-phenanthroline-5,6-dione in 1 studies
| Studies (dactylariol) | Trials (dactylariol) | Recent Studies (post-2010) (dactylariol) | Studies (1,10-phenanthroline-5,6-dione) | Trials (1,10-phenanthroline-5,6-dione) | Recent Studies (post-2010) (1,10-phenanthroline-5,6-dione) |
|---|---|---|---|---|---|
| 5 | 0 | 4 | 40 | 0 | 22 |
| Protein | Taxonomy | dactylariol (IC50) | 1,10-phenanthroline-5,6-dione (IC50) |
|---|---|---|---|
| RNA-editing ligase 1, mitochondrial | Trypanosoma brucei brucei | 3.51 | |
| putative polyprotein | 5.384 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cechinel Filho, V; Corrêa, R; Klein-Júnior, LC; Vander Heyden, Y | 1 |
1 review(s) available for dactylariol and 1,10-phenanthroline-5,6-dione
| Article | Year |
|---|---|
All that glitters is not gold: Panning cytotoxic natural products and derivatives with a fused tricyclic backbone by the estimation of their leadlikeness for cancer treatment.
Topics: Antineoplastic Agents; Biological Products; Chemical Phenomena; Humans; Macrocyclic Compounds | 2019 |